Invention Grant
- Patent Title: Intracellular ATP enhancer
-
Application No.: US15754842Application Date: 2016-08-24
-
Publication No.: US10682372B2Publication Date: 2020-06-16
- Inventor: Takeshi Nishino , Naoyuki Kamatani
- Applicant: StaGen Co., Ltd.
- Applicant Address: JP Tokyo
- Assignee: STAGEN CO., LTD.
- Current Assignee: STAGEN CO., LTD.
- Current Assignee Address: JP Tokyo
- Agency: Birch, Stewart, Kolasch & Birch, LLP
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@6569ca69
- International Application: PCT/JP2016/074644 WO 20160824
- International Announcement: WO2017/033963 WO 20170302
- Main IPC: A61K31/426
- IPC: A61K31/426 ; A61K31/708 ; A61K31/4439 ; A61K31/405 ; A61K9/20 ; A61K31/415 ; A61K45/06 ; A61K31/522 ; A61K31/045 ; A61K31/519

Abstract:
A problem to be solved by the present invention is to provide a substance having an effect of increasing intracellular ATP and, particularly, a potent ATP enhancer far surpassing the increasing effect of inosine or febuxostat alone.A human or animal intracellular ATP enhancer comprising a combination of A) and B): A) a xanthine oxidase/xanthine dehydrogenase inhibitor or a pharmaceutically acceptable salt thereof; and B) any one or more compounds selected from inosine, inosinic acid, hypoxanthine, and pharmaceutically acceptable salts thereof.
Public/Granted literature
- US20180243326A1 INTRACELLULAR ATP ENHANCER Public/Granted day:2018-08-30
Information query
IPC分类: